Effects of Aripiprazole in Overweight Patients Treated With Olanzapine for Schizophrenia or Schizoaffective Disorder

Phase 3CompletedNCT00095524

Otsuka Pharmaceutical Development & Commercialization, Inc.300 enrolled

Overview

The primary purpose of this study is to compare the affects of aripiprazole and olanzapine on weight change.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

DOUBLE

Enrollment

300

Conditions

Body Weight Change Schizophrenia Schizoaffective Disorder Psychotic Disorder

Interventions

AripiprazoleDRUG

Eligibility

Sex: ALLMin age: 18 YearsMax age: 65 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Adult patients diagnosed with schizophrenia or schizoaffective disorder who are currently taking olanzapine.

Locations (32)

Outcomes

Primary Outcomes

Comparison of weight change from baseline to Week 16 in patients with schizophrenia or schizoaffective disorder treated with aripiprazole or olanzapine

Secondary Outcomes

Assessment of metabolic laboratory measures

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.

Local Institution

Little Rock, Arkansas, United States

Local Institution

Anaheim, California, United States

Local Institution

Cerritos, California, United States

Local Institution

Garden Grove, California, United States

Local Institution

National City, California, United States

Local Institution

San Diego, California, United States

Local Institution

New Britain, Connecticut, United States

Local Institution

North Miami, Florida, United States

Local Institution

Augusta, Georgia, United States

Local Institution

Macon, Georgia, United States

...and 22 more locations